Our studies suggest that the ability of Nf2−/− SCs to variably enact distinct programs of ErbB ligand production and cytoskeletal polarity upon loss of axonally provided nutrients is a key intrinsic driver of schwannoma heterogeneity. Here, EGFR is linked to schwannoma.